COMMUNIQUÉS West-GlobeNewswire

Mateon Therapeutics Reports First Quarter 2018 Financial Results
14/05/2018
SOUTH SAN FRANCISCO, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]
Precipio Announces Preliminary Q1 2018 Year-over-Year Revenue Increase of 286%
14/05/2018
Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization NEW HAVEN, Conn., May 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, [...]
Auris Medical to Report First Quarter 2018 Financial Results and Provide Business and Strategy Update on Tuesday, May 15, 2018
14/05/2018
Zug, Switzerland, May 14, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced that it [...]
Cannabis Wheaton Announces Exclusive License for Dixie Brands’ Cannabinoid-Infused Products in Canada and Mexico
14/05/2018
VANCOUVER, British Columbia, May 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX-V: CBW ) (“ Cannabis Wheaton ” or the “ Company ”) is pleased to announce that it has entered into a definitive licensing [...]
VitalHub Introduces Harm Reduction Software
14/05/2018
TORONTO, May 14, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) is pleased to announce the introduction of a harm reduction module, aimed at the growing opioid epidemic facing North [...]
New Scientific Advisors Focused on Cell Therapy in Immuno-Oncology and Autoimmunity Join Intellia Therapeutics
14/05/2018
CAMBRIDGE, Mass., May 14, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA ), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology, announced new [...]
Marinus Pharmaceuticals to Present at the UBS Global Healthcare Conference
14/05/2018
RADNOR, Pa., May 14, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric [...]
Transactions under Novozymes’ stock buyback program
14/05/2018
Please read the full announcement in the attached PDF Attachment 2018_31_Stock_Buybackprogram_EN
Trading by management and close relations of management
14/05/2018
Read the full announcement in the attached file Attachment 2018_30_Trading_by_management_EN
Share buy-back week 19/2018
14/05/2018
Announcement 14 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]
ChromaDex Appoints Nobel Laureate, Professor Sir John Walker, to the Scientific Advisory Board
14/05/2018
World-Renowned British Chemist to Assist in Uncovering New Applications for Nicotinamide Riboside and Mitochondrial Health IRVINE, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated [...]
Evoke Pharma Reports First Quarter 2018 Results and Highlights
14/05/2018
The Company will hold a conference call following submission of Gimoti NDA NDA submission for Gimoti™ on track for second quarter of 2018 Announced discovery of sex-based pharmacokinetic differences for Gimoti Waiver of [...]
Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in May and June
14/05/2018
Press Release 14 May 2018 Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in May and June Immunicum AB (publ; IMMU.ST) today announced that Company leadership will present the [...]
Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch Clinical Study
14/05/2018
IRB Approval Signals ‘Green Light’ for Sernova’s Clinical Protocol to Proceed LONDON, Ontario, May 14, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V: SVA ) (OTCQB:SEOVF) (FSE:PSH), announces today it has received [...]
OraSure Technologies to Present at the UBS Global Healthcare Conference
14/05/2018
BETHLEHEM, Pa., May 14, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President [...]
Healthwise Recognized for Plain-Language Excellence With 2018 Grand ClearMark Award
14/05/2018
BOISE, Idaho, May 14, 2018 (GLOBE NEWSWIRE) -- When people get health information they understand, they can make better health decisions. For over 40 years Healthwise has written clear and simple health education that [...]
Fennec Provides Business Update and Announces First Quarter 2018 Financial Results
14/05/2018
PEDMARK TM granted Breakthrough Therapy and Fast Track Designations by FDA Actively preparing for NDA submission later this year Strong financial position with $26.7 million in cash and no debt RESEARCH TRIANGLE PARK, N [...]
Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection
14/05/2018
RANCHO CUCAMONGA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that the U.S. Food and Drug Administration (“FDA”) granted approval of the company’s abbreviated new [...]
International Endeavors Corporation, a Medical Marijuana IP Holdings Company, Secures a $500,000 Investment Commitment From Voltage River
14/05/2018
TEMECULA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation, a Medical Marijuana IP Holdings Company, today announces that the Company has received an investment commitment of [...]

Pages